An Binh Dang

Dr. An Binh Dang

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2023 in European Eating Disorders Review
Verified
Journal Article
Closed access
ADAn Binh Dang
An Binh Dang
LKLitza Kiropoulos
Litza Kiropoulos
DCDavid J. Castle
David J. Castle
ZJZoe Jenkins
Zoe Jenkins
APAndrea Phillipou
Andrea Phillipou
Isabel KrugIsabel Krug
Isabel Krug

1 December 2022 in Clinical Psychology: Science and Practice
Verified
Journal Article
Closed access
ADAn Binh Dang
An Binh Dang
SGSarah Giles
Sarah Giles
MFMatthew Fuller-Tyszkiewicz
Matthew Fuller-Tyszkiewicz
LKLitza Kiropoulos
Litza Kiropoulos
Isabel KrugIsabel Krug
Isabel Krug

28 November 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
Isabel KrugIsabel Krug
Isabel Krug
ADAn Binh Dang
An Binh Dang
JPJade Portingale
Jade Portingale
YLYakun Li
Yakun Li
YWYing Qing Won
Ying Qing Won
Background: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have transformed treatment for higher weight and diabetes. Because they also influence appetite and reward processes, these medications may shape eating behaviours, emotions, and body image, raising new challenges for eating disorder (ED) research and clinical care. This narrative review synthesises emerging evidence on the psychological and behavioural effects of GLP-1RA use within a biopsychosocial and equity framework. Method: Using a narrative, non-systematic approach, we conducted targeted searches across major databases (2015–September 2025) with combined GLP-1RA and psychological or ED-related terms, supplemented by cross-referencing. Inclusion criteria focused on empirical, theoretical, and clinically meaningful psychological, behavioural, and sociocultural outcomes, enabling a conceptually driven synthesis of the psychological effects of GLP-1RA use. Results: GLP-1RAs reduce hunger and binge-eating frequency, suggesting possible benefits for binge-type EDs. However, evidence for restrictive EDs remains limited, and appetite suppression may reinforce rigid control or perfectionistic traits. Although short-term reductions in emotional eating have been reported, the long-term psychological safety of GLP-1RAs is unknown. Rapid, medication-driven weight loss may disrupt body perception, while social media discourse glamorises thinness and intensifies stigma. These psychosocial effects intersect with inequities in access, disproportionately affecting adolescents and individuals from culturally diverse or socioeconomically marginalised groups. Conclusions: GLP-1RAs sit at the intersection of medical innovation and psychological risk. To ensure safe and inclusive use, research and clinical practice should integrate developmental, cultural, and lived-experience perspectives. Co-designed research and multidisciplinary monitoring will be essential to reduce stigma, address inequities, and support psychologically informed care.

25 October 2024 in International Journal of Eating Disorders
Verified
Journal Article
Open access
TDThanh Ba Dang
Thanh Ba Dang
EHElizabeth K. Hughes
Elizabeth K. Hughes
ADAn Binh Dang
An Binh Dang
HLHeung Ying Lai
Heung Ying Lai
JLJessica Lee
Jessica Lee
Isabel KrugIsabel Krug
Isabel Krug
Objective: To compare all other specified feeding or eating disorders (OSFED) groups (atypical anorexia nervosa [AN], purging disorder [PD], night eating syndrome [NES], subthreshold bulimia nervosa [sub‐BN], and subthreshold binge‐eating disorder [sub‐BED]) to threshold eating disorders (EDs [AN, BN, and BED]) and control groups (CGs) on measures of eating and general psychopathology.Method: We conducted a comprehensive search in PsycINFO, Medline, Embase, and CINAHL on all published studies from January 2013 to February 2024 using DSM‐5 diagnostic criteria via clinical interviews or well‐established diagnostic tools. We also undertook a quality appraisal using an adapted version of the Downs and Black criteria and registered the review with PROSPERO (ID: CRD42022314495).Results: Overall, our meta‐analyses (n = 33 eligible studies) indicated that the combined OSFED and several specific OSFED subtypes displayed comparable levels of eating psychopathology to full‐threshold EDs. Our systematic review (n = 33 eligible studies) found individuals with OSFED to have comparable levels of eating and general psychopathology to full‐threshold EDs, but higher levels of eating and general psychopathology than CGs. These findings were specifically attributed to atypical AN and NES. There was a lack of evidence available for sub‐BN and sub‐BED. Studies mainly met the quality appraisal criteria. The main limitations identified in the included studies were insufficient reporting of their statistical power (78%) and no adjusting for potential confounding factors (67%).Discussion: Findings support the conceptualization of atypical AN, and NES as clinically significant EDs with similar severity to full‐threshold EDs.

23 December 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
Isabel KrugIsabel Krug
Isabel Krug
ADAn Binh Dang
An Binh Dang
ELEvonne Lu
Evonne Lu
WOWenn Lynn Ooi
Wenn Lynn Ooi
JPJade Portingale
Jade Portingale
SMStephanie Miles
Stephanie Miles
Background/Objectives: Recent research has increasingly explored the cognitive processes underlying eating disorders (EDs), including anorexia nervosa (AN), bulimia nervosa (BN), binge eating disorder (BED), other specified feeding or eating disorders (OSFEDs), and individuals with higher weight (HW). This critical narrative review focuses on neurocognitive findings derived from mainly experimental tasks to provide a detailed understanding of cognitive functioning across these groups. Where experimental data are lacking, we draw on self-report measures and neuroimaging findings to offer supplementary insights. Method: A search of major databases that prioritized meta-analyses and recent publications (last 10 years) was conducted. Using comprehensive search terms related to EDs, HW, and neurocognition, eligible studies focused on human neurocognitive outcomes (e.g., cognitive flexibility, attentional bias, etc.) published in English were selected. Results: We found that some neurocognitive characteristics, such as cognitive rigidity, impulsivity, emotion processing difficulties, and dysregulated reward processing, appear transdiagnostic, spanning multiple ED subtypes and HW populations. We also revealed neurocognitive features specific to ED subtypes and HW. For instance, individuals with AN demonstrate an enhanced focus on detail, and BN and BED are characterized by a pronounced attentional bias toward food-related stimuli. In individuals with HW, cognitive processes underpin behaviours associated with overeating and weight gain. Conclusions: These findings highlight the critical importance of understanding both the unique and shared neurocognitive patterns across ED subtypes and HW populations. By identifying transdiagnostic factors, such as cognitive rigidity and reward processing, alongside ED subtype/HW-specific vulnerabilities, researchers and clinicians can develop more nuanced, evidence-based interventions that address the core mechanisms driving disordered eating behaviours.

22 November 2024 in European Eating Disorders Review
Verified
Journal Article
Closed access
ADAn Binh Dang
An Binh Dang
RGRoser Granero
Roser Granero
ISIsabel Sanchez
Isabel Sanchez
LSLaura Gálvez Solé
Laura Gálvez Solé
JTJessica Jimenez‐Del Toro
Jessica Jimenez‐Del Toro
FFFernando Fernandez‐Aranda
Fernando Fernandez‐Aranda